We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info . X close

Research Antibodies & Reagents Market: Growth, Size, Share, and Trends

Report Code BT 5482
Published in Oct, 2023, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Research Antibodies & Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western blot, Flow Cytometry, ELISA), Application (Proteomics, Genomics), End User (Pharma, Biotech, CROs) & Region - Global forecast to 2028

Overview

The process mining market is anticipated to grow rapidly, reaching a value of USD 12.1 billion by 2028 from USD 1.8 billion in 2023. Over the course of the projected period at a CAGR of 45.6%. The rapid expansion of the process mining market can be attributed to several key drivers, as organizations navigate through intricate processes, there's a heightened necessity for tools that can adeptly dissect and optimize these complexities, the pervasive wave of digital transformation has evolved into a tidal force, with businesses across sectors increasingly integrating advanced technologies and process mining serves as the compass, illuminating the intricate pathways of operations, fostering transparency, and empowering organizations with the control needed to navigate through the intricacies of modern business environments.

Attractive Opportunities in the Research Antibodies & Reagents Market

NORTH AMERICA:

North America has been at the forefront of technological innovations. With a well-established IT infrastructure and a culture of early technology adoption, businesses in the region are likely to embrace process mining tools to enhance efficiency and competitiveness. North America has a vibrant start-up ecosystem that often drives innovation.

The growth of this market can be attributed to growing trend of increased investment in analytics and BI tools and North America being a hub for multinational corporations, the need for efficient and optimized processes to maintain global competitiveness is significant.

In North America, continuous monitoring & analytics tool is slated to be the largest software segment by market share in 2023.

Partnerships, collaborations, and product launches would offer lucrative opportunities for market players in the next five years.

In North America development of user-friendly and cost-effective process mining solutions specifically designed for small and medium-sized enterprises presents an untapped market for accessible process mining tools.

Global Research Antibodies & Reagents Market Dynamics

Driver: Increasing complexity of business processes

With businesses engaging in diverse and interdependent operations globally, the intricate network of workflows is further compounded by the integration of technologies such as ERP systems, CRMs, and RPA. Stringent regulatory compliance requirements, coupled with the imperative to meet customer expectations for personalized experiences, contribute to the multifaceted nature of these processes. Process mining emerges as a vital tool, providing real-time visibility, actionable insights, and historical perspectives to unravel the complexities, optimize operations, and drive informed decision-making in the ever-evolving landscape of modern business.

Restraint: Data security and privacy concerns

In this modern era, where organizations increasingly rely on process mining solutions to optimize their operations, the sensitivity and confidentiality of data cannot be overstated. As businesses delve into the intricate details of their processes through mining, there is a growing apprehension about the security of the data being analyzed. Companies handle vast amounts of proprietary information, including customer data, financial records, and internal operations data, making them susceptible to breaches. The reluctance to adopt process mining tools often stems from the fear that exposing such granular insights may inadvertently lead to data leaks or unauthorized access. Compliance with data protection regulations, such as GDPR, adds an additional layer of complexity, necessitating stringent measures to ensure adherence. This concern is particularly pronounced in industries dealing with highly regulated information, such as finance and healthcare, where the repercussions of a security breach can be severe, including legal actions, financial penalties, and reputational damage.

 

Opportunity: Artificial intelligence and machine learning integration

As organizations across various sectors strive for operational excellence and efficiency, the synergy between AI, ML, and Process Mining emerges as a powerful solution. AI and ML technologies enhance Process Mining capabilities by enabling advanced data analysis and predictive insights. Process Mining involves the extraction of knowledge from event logs to discover, monitor, and improve business processes. When integrated with AI and ML, it transcends mere retrospective analysis, offering proactive and real-time decision-making support. One key aspect is the ability of AI and ML algorithms to handle large and complex datasets, allowing for more comprehensive process mapping and analysis. This, in turn, facilitates the identification of inefficiencies, bottlenecks, and opportunities for optimization within business processes. The predictive analytics offered by ML algorithms further empower organizations to forecast potential process deviations, enabling preemptive corrective actions.

Challenge:Interpreting complex insights

Process Mining tools are adept at extracting and analyzing vast amounts of data to provide valuable insights into business processes. However, the sheer volume and intricacy of the generated data often pose a usability challenge for end-users. The complexity arises from the diverse sources of data, intricate process interdependencies, and the nuanced nature of business workflows. Organizations may struggle to derive actionable insights from the wealth of information presented by Process Mining tools, hindering effective decision-making. The challenge of interpreting complex insights translates into a potential bottleneck for deriving meaningful and strategic conclusions. This complexity can overwhelm users, leading to difficulties in identifying key patterns, bottlenecks, or areas for improvement in their processes.

Global Research Antibodies & Reagents Market Ecosystem Analysis

By offering, continuous monitoring & analytics tools software segment to account for a larger market size during forecast period The software segment of the process mining market includes various software solutions that cater to the needs of several industries. Continuous analytics allow organizations to continuously optimize their processes based on real-time data. This iterative improvement cycle ensures that businesses are always operating at peak performance, meeting customer expectations, and adapting to changing market dynamics effectively. These tools enable proactive issue identification and resolution. By constantly analyzing processes, they can detect anomalies or inefficiencies before they escalate. This proactive approach aligns with the modern business ethos of preventing problems rather than reacting to them, contributing to smoother operations.

 

By mining algorithm, discovery algorithms segment to hold the largest market share during the forecast period

In an era marked by increasingly complex business operations, discovery algorithms showcase a remarkable adaptability. They excel in handling intricate process structures and variations, making them indispensable for industries with multifaceted workflows. This adaptability positions them as the go-to solution for businesses navigating intricate operational scenarios. The iterative nature of discovery algorithms allows for continuous monitoring of processes. As businesses evolve and adapt to changing market dynamics, these algorithms facilitate real-time insights into ongoing operations.

By data source, financial systems data segment to register the fastest growth rate during the forecast period

Financial systems form the backbone of any organization, serving as the nerve center for monetary transactions, budgeting, and financial planning. As businesses increasingly recognize the pivotal role of finance in overall operational health, the demand for process mining within financial systems intensifies. Financial processes are inherently complex, involving numerous steps and stakeholders. Process mining excels in unraveling intricate workflows, identifying bottlenecks, and optimizing processes for efficiency. The financial systems data segment benefits significantly from the ability of process mining to streamline these intricate financial workflows.

EUROPE Region Holds the Largest Share of the Research Antibodies & Reagents Market

Process mining's versatility makes it applicable across a wide range of industries, from manufacturing to finance. Europe, with its diverse economic landscape, sees widespread adoption of process mining solutions across various sectors, contributing to the region's overall market share. Supportive government initiatives and funding for digital transformation projects further propel the adoption of process mining in Europe. This creates an environment conducive to innovation and technological advancement, fostering the growth of the process mining market in the region.

 
 

Recent Developments of Research Antibodies & Reagents Market Industry

  • In July 2023, Microsoft announced the launch of Power Automate Process Mining, infused with next-generation AI which enables organizations to easily understand what is happening across their business, maximize process insights, use out-of-box recommendations to reduce the complexity of processes, transform operations, and drive continuous process improvement with automation and low-code apps. In May 2023, Pegasystems announced the launch of Pega Process Mining, which will make it easier for Pega users of all skill levels to find and fix process inefficiencies hindering their business operations. In May 2023, QPR Software announced a brand-new partnership with Paris-based Solution BI, known for their customer-centric end-to-end business intelligence solutions.
  • In March 2023, UiPath launched a new process mining tool called Communications Mining which brings new capabilities to understand and automate business communications. It uses state-of-the-art AI models to turn business messages—from emails to tickets—into actionable data. In January 2023, Appian announced a strategic alliance with EY to support clients on digital transformation initiatives using the next wave of intelligent automation and process mining.

Key Market Players

Key Players in the Research Antibodies & Reagents Market Include

Want to explore hidden markets that can drive new revenue in Research Antibodies & Reagents Market?

Scope of the Report

Report Attribute Details
Market size available for years 2018–2028
Base year considered 2022
Forecast period 2023–2028
Forecast units USD (Billion)
Segments covered Offering, Mining Algorithms, Data Source, Vertical, and Region
Geographies covered North America, Europe, Asia Pacific, Middle East & Africa, and Latin America
Companies covered IBM (US), ABBYY (US), Celonis (US), UiPath (US), Software AG (Germany), SAP Signavio (Germany), QPR Software (Finland), Microsoft (US), Appian (US), Pegasystems (US), Mehrwerk (Germany), Kofax (US), Soroco (US), iGrafx (US), Nintex (US), Automation Anywhere (US), Hyland Software (US), Fluxicon (Netherlands), Datapolis (Poland), Apromore (Australia), BusinessOptix (US), StereoLOGIC (Canada), Worksoft (US), Inverbis Analytics (Spain), Skan.ai (US), Mindzie (US), Cyclone Robotics (China), Upflux (Brazil), Puzzledata Inc. (South Korea), Kyp.ai (Germany), Workfellow (Finland).

Key Questions Addressed by the Report

What is process mining?
Process mining is a method of applying specialized algorithms to discover, validate and improve workflows. By combining data mining and process analytics, organizations can mine log data from their information systems to understand the performance of their processes, revealing bottlenecks and other areas of improvement. Process mining leverages a data-driven approach to process optimization, allowing managers to remain objective in their decision-making around resource allocation for existing processes.
What is the total CAGR expected to be recorded for the process mining market during 2023-2028?
The market is expected to record a CAGR of 45.6% from 2023-2028.
Which are the major growth enablers catalyzing the process mining market?
The process mining market is being majorly driven by factors such as increasing complexity of business processes, rising adoption of digital transformation, and growing need for process visibility and control.
Which are the top three process mining tools prevailing in the process mining market?
Continuous monitoring and analytics tools, process discovery tools, and conformance checking tools are among the top-3 process mining tools in terms of adoption because they offer organizations the ability to gain real-time insights into their business processes, identify bottlenecks and inefficiencies, ensure compliance with desired process models, and make data-driven decisions.
Who are the key vendors in the process mining market?
Some major players in the process mining market include IBM (US), ABBYY (US), Celonis (US), UiPath (US), Software AG (Germany), SAP Signavio (Germany), QPR Software (Finland), Microsoft (US), Appian (US), Pegasystems (US), Mehrwerk (Germany), Kofax (US), Soroco (US), iGrafx (US), Nintex (US), Automation Anywhere (US), Hyland Software (US), Fluxicon (Netherlands), Datapolis (Poland), Apromore (Australia), BusinessOptix (US), StereoLOGIC (Canada), Worksoft (US), Inverbis Analytics (Spain), Skan.ai (US), Mindzie (US), Cyclone Robotics (China), Upflux (Brazil), Puzzledata Inc. (South Korea), Kyp.ai (Germany), Workfellow (Finland).

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Research Antibodies & Reagents Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
34
RESEARCH METHODOLOGY
39
EXECUTIVE SUMMARY
53
PREMIUM INSIGHTS
59
MARKET OVERVIEW
63
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Rising funding for life sciences research
    - Increasing industry-academia collaborations
    - Growing applications of biomarker identification & validation
    RESTRAINTS
    - Quality concerns and inadequacy of reproducible results
    - Ethical concerns for animal welfare in antibody production
    OPPORTUNITIES
    - High-growth potential of emerging economies
    - Personalized medicine and protein therapeutics
    - Growth in stem cell and neurobiology research
    - Outsourcing services to CROs
    CHALLENGES
    - Complexities associated with antibody development
    - Increasing pricing pressure
  • 5.3 INDUSTRY TRENDS
    GROWING R&D ON THERAPEUTIC ANTIBODIES
    OPTIMAL USAGE OF RECOMBINANT ANTIBODIES
  • 5.4 SUPPLY CHAIN ANALYSIS
  • 5.5 PRODUCT PORTFOLIO ANALYSIS
  • 5.6 TECHNOLOGY ANALYSIS
  • 5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.8 PRICING ANALYSIS
    INDICATIVE PRICING ANALYSIS, BY ANTIBODIES
    INDICATIVE PRICING ANALYSIS OF OVERALL MARKET (QUALITATIVE ANALYSIS)
  • 5.9 TRADE ANALYSIS (HS CODES)
  • 5.10 ECOSYSTEM ANALYSIS
    ROLE IN ECOSYSTEM
  • 5.11 PATENT ANALYSIS
  • 5.12 KEY CONFERENCES AND EVENTS
  • 5.13 REGULATORY ANALYSIS
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.14 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT
89
  • 6.1 INTRODUCTION
  • 6.2 REAGENTS
    MEDIA & SERA
    - Critical component in cell culture to boost demand
    STAINS & DYES
    - Growing applications in cell biology and molecular studies to fuel uptake
    FIXATIVES
    - High utilization in immunohistochemistry and western blotting to propel market
    BUFFERS
    - High utilization in drug development to drive market
    SOLVENTS
    - Broad applications in pharmaceutical processes and IHC assays to propel market
    ENZYMES
    - Rising proteomic & genomic research studies to fuel uptake
    PROBES
    - Quantitative and versatile capabilities to propel market
    OTHER REAGENTS
  • 6.3 ANTIBODIES
    ANTIBODIES, BY TYPE
    - Primary antibodies
    - Secondary antibodies
    ANTIBODIES, BY FORM
    - Monoclonal antibodies
    - Polyclonal antibodies
    - Recombinant antibodies
    ANTIBODIES, BY SOURCE
    - Mice
    - Rabbits
    - Other sources
    ANTIBODIES, BY RESEARCH AREA
    - Oncology
    - Infectious diseases
    - Immunology
    - Neurobiology
    - Stem cells
    - Other research areas
RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY
157
  • 7.1 INTRODUCTION
  • 7.2 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)
    ABILITY TO DETECT ONCOLOGY AND INFECTIOUS DISEASE SAMPLES TO PROPEL MARKET
  • 7.3 FLOW CYTOMETRY
    GROWING APPLICATIONS IN CANCER RESEARCH TO DRIVE MARKET
  • 7.4 WESTERN BLOTTING
    HIGH ACCURACY AND SIMPLIFIED ASSESSMENT TO DRIVE MARKET
  • 7.5 IMMUNOFLUORESCENCE
    ABILITY TO DETERMINE SPECIFIC GENE EXPRESSIONS TO SUPPORT MARKET
  • 7.6 IMMUNOHISTOCHEMISTRY
    GROWING APPLICATIONS IN DRUG EFFICACY TESTING TO SUPPORT MARKET GROWTH
  • 7.7 IMMUNOPRECIPITATION
    HIGH-SPECIFICITY RESULTS TO CONTRIBUTE TO MARKET GROWTH
  • 7.8 OTHER TECHNOLOGIES
RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION
179
  • 8.1 INTRODUCTION
  • 8.2 PROTEOMICS
    RISING GOVERNMENT INVESTMENTS IN RESEARCH PROJECTS TO DRIVE MARKET
  • 8.3 DRUG DEVELOPMENT
    RISING PHARMA R&D EXPENDITURE TO PROPEL MARKET
  • 8.4 GENOMICS
    INCREASING INVESTMENTS IN GENOMICS MEDICINE TO SUPPORT MARKET GROWTH
RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER
191
  • 9.1 INTRODUCTION
  • 9.2 RESEARCH LABORATORIES
    INCREASING STUDIES IN BIOMEDICAL AND LIFE SCIENCE RESEARCH TO PROPEL MARKET
  • 9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    RISING FOCUS ON DRUG DEVELOPMENT TO DRIVE MARKET
  • 9.4 CONTRACT RESEARCH ORGANIZATIONS
    ASSISTED SERVICES FOR MAB DEVELOPMENT TO SUPPORT MARKET GROWTH
RESEARCH ANTIBODIES AND REAGENTS MARKET, BY REGION
201
  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    US
    - Increasing funding for oncology therapeutics to drive market
    CANADA
    - Rising funding for biomedical research projects to drive market
    NORTH AMERICA: RECESSION IMPACT
  • 10.3 EUROPE
    GERMANY
    - Growing industry-academia collaborations for life science research to drive market
    UK
    - Rising incidence of cancer to support market growth
    FRANCE
    - Rising demand for personalized therapeutics to support market growth
    ITALY
    - Federal funding for targeted research projects to support market growth
    SPAIN
    - Favorable funding initiatives for novel therapeutic development to propel market
    REST OF EUROPE
    EUROPE: RECESSION IMPACT
  • 10.4 ASIA PACIFIC
    CHINA
    - Rising establishment of R&D facilities to propel market
    JAPAN
    - Rising growth in biotechnology industry to propel market
    INDIA
    - Rising growth in pharmaceutical industry to drive market
    REST OF ASIA PACIFIC
    ASIA PACIFIC: RECESSION IMPACT
  • 10.5 LATIN AMERICA
    BRAZIL
    - Growing hub for pharma R&D to support market growth
    REST OF LATIN AMERICA
    LATIN AMERICA: RECESSION IMPACT
  • 10.6 MIDDLE EAST & AFRICA
    MIDDLE EAST
    - Rising research collaborations to drive market
    AFRICA
    - Growing genomic studies to support market growth
    MIDDLE EAST & AFRICA: RECESSION IMPACT
COMPETITIVE LANDSCAPE
293
  • 11.1 OVERVIEW
  • 11.2 STRATEGIES ADOPTED BY KEY PLAYERS
  • 11.3 MARKET SHARE ANALYSIS
    RESEARCH ANTIBODIES AND REAGENTS MARKET: MARKET SHARE ANALYSIS
    RESEARCH ANTIBODIES MARKET: MARKET SHARE ANALYSIS (2022)
  • 11.4 REVENUE SHARE ANALYSIS OF TOP PLAYERS
  • 11.5 COMPANY EVALUATION MATRIX
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT
    - Company footprint (25 Companies)
    - Company product footprint (25 Companies)
    - Company regional footprint (25 Companies)
  • 11.6 START-UP/SME EVALUATION MATRIX
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
  • 11.7 COMPETITIVE TRENDS
COMPANY PROFILES
310
  • 12.1 KEY PLAYERS
    ABCAM PLC
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    CELL SIGNALING TECHNOLOGY, INC.
    - Business overview
    - Products offered
    - MnM view
    THERMO FISHER SCIENTIFIC INC.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    MERCK KGAA
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    BECTON, DICKINSON AND COMPANY
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    BIO-RAD LABORATORIES, INC.
    - Business overview
    - Products offered
    - Recent developments
    F. HOFFMANN-LA ROCHE LTD.
    - Business overview
    - Products offered
    - Recent developments
    AGILENT TECHNOLOGIES, INC.
    - Business overview
    - Products offered
    - Recent developments
    DANAHER
    - Business overview
    - Products offered
    - Recent developments
    LONZA GROUP
    - Business overview
    - Products offered
    - Recent developments
    GENSCRIPT
    - Business overview
    - Products offered
    - Recent developments
    REVVITY
    - Business overview
    - Products offered
    - Recent developments
    ILLUMINA, INC.
    - Business overview
    - Products offered
    - Recent developments
  • 12.2 OTHER PLAYERS
    IMMUNOPRECISE ANTIBODIES LTD.
    FUJIREBIO
    ANALYTIK JENA GMBH+CO. KG
    OMEGA BIO-TEK, INC.
    DOVETAIL GENOMICS
    ATLAS ANTIBODIES AB
    ROCKLAND IMMUNOCHEMICALS, INC.
    SANTA CRUZ BIOTECHNOLOGY, INC.
    JACKSON IMMUNORESEARCH INC.
    PROTEINTECH GROUP, INC.
    ICL, INC.
    SOUTHERNBIOTECH
APPENDIX
376
  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2028 (% GROWTH)
  • TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
  • TABLE 3 US HEALTH EXPENDITURE, 2023–2028 (USD MILLION)
  • TABLE 4 RESEARCH ANTIBODIES AND REAGENTS MARKET: IMPACT ANALYSIS
  • TABLE 5 RESEARCH ANTIBODIES AND REAGENTS MARKET: PRODUCT PORTFOLIO ANALYSIS
  • TABLE 6 INDICATIVE PRICING OF ANTIBODIES, BY KEY PLAYERS (2022)
  • TABLE 7 EXPORT DATA FOR DIAGNOSTIC OR LABORATORY REAGENTS (HS CODE 3822), 2018–2022 (USD THOUSAND)
  • TABLE 8 IMPORT DATA FOR DIAGNOSTIC OR LABORATORY REAGENTS (HS CODE 3822), 2018–2022 (USD THOUSAND)
  • TABLE 9 INDICATIVE LIST OF PATENTS IN RESEARCH ANTIBODIES AND REAGENTS MARKET
  • TABLE 10 RESEARCH ANTIBODIES AND REAGENTS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS (2023−2024)
  • TABLE 11 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 RESEARCH ANTIBODIES AND REAGENTS MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 13 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 14 REAGENTS, BY TYPE AND APPLICATION
  • TABLE 15 RESEARCH REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 16 RESEARCH REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 17 NORTH AMERICA: RESEARCH REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 18 EUROPE: RESEARCH REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 19 ASIA PACIFIC: RESEARCH REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 20 LATIN AMERICA: RESEARCH REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 21 MIDDLE EAST & AFRICA: RESEARCH REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 22 RESEARCH REAGENTS MARKET FOR MEDIA & SERA, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 23 NORTH AMERICA: RESEARCH REAGENTS MARKET FOR MEDIA & SERA, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 24 EUROPE: RESEARCH REAGENTS MARKET FOR MEDIA & SERA, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 25 ASIA PACIFIC: RESEARCH REAGENTS MARKET FOR MEDIA & SERA, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 26 LATIN AMERICA: RESEARCH REAGENTS MARKET FOR MEDIA & SERA, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 27 MIDDLE EAST & AFRICA: RESEARCH REAGENTS MARKET FOR MEDIA & SERA, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 28 RESEARCH REAGENTS MARKET FOR STAINS & DYES, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 29 NORTH AMERICA: RESEARCH REAGENTS MARKET FOR STAINS & DYES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 30 EUROPE: RESEARCH REAGENTS MARKET FOR STAINS & DYES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 31 ASIA PACIFIC: RESEARCH REAGENTS MARKET FOR STAINS & DYES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 32 LATIN AMERICA: RESEARCH REAGENTS MARKET FOR STAINS & DYES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 33 MIDDLE EAST & AFRICA: RESEARCH REAGENTS MARKET FOR STAINS & DYES, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 34 RESEARCH REAGENTS MARKET FOR FIXATIVES, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 35 NORTH AMERICA: RESEARCH REAGENTS MARKET FOR FIXATIVES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 36 EUROPE: RESEARCH REAGENTS MARKET FOR FIXATIVES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 37 ASIA PACIFIC: RESEARCH REAGENTS MARKET FOR FIXATIVES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 38 LATIN AMERICA: RESEARCH REAGENTS MARKET FOR FIXATIVES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 39 MIDDLE EAST & AFRICA: RESEARCH REAGENTS MARKET FOR FIXATIVES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 40 RESEARCH REAGENTS MARKET FOR BUFFERS, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 41 NORTH AMERICA: RESEARCH REAGENTS MARKET FOR BUFFERS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 42 EUROPE: RESEARCH REAGENTS MARKET FOR BUFFERS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 43 ASIA PACIFIC: RESEARCH REAGENTS MARKET FOR BUFFERS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 44 LATIN AMERICA: RESEARCH REAGENTS MARKET FOR BUFFERS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 45 MIDDLE EAST & AFRICA: RESEARCH REAGENTS MARKET FOR BUFFERS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 46 RESEARCH REAGENTS MARKET FOR SOLVENTS, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 47 NORTH AMERICA: RESEARCH REAGENTS MARKET FOR SOLVENTS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 48 EUROPE: RESEARCH REAGENTS MARKET FOR SOLVENTS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 49 ASIA PACIFIC: RESEARCH REAGENTS MARKET FOR SOLVENTS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 50 LATIN AMERICA: RESEARCH REAGENTS MARKET FOR SOLVENTS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 51 MIDDLE EAST & AFRICA: RESEARCH REAGENTS MARKET FOR SOLVENTS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 52 RESEARCH REAGENTS MARKET FOR ENZYMES, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 53 NORTH AMERICA: RESEARCH REAGENTS MARKET FOR ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 54 EUROPE: RESEARCH REAGENTS MARKET FOR ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 55 ASIA PACIFIC: RESEARCH REAGENTS MARKET FOR ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 56 LATIN AMERICA: RESEARCH REAGENTS MARKET FOR ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 57 MIDDLE EAST & AFRICA: RESEARCH REAGENTS MARKET FOR ENZYMES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 58 RESEARCH REAGENTS MARKET FOR PROBES, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 59 NORTH AMERICA: RESEARCH REAGENTS MARKET FOR PROBES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 60 EUROPE: RESEARCH REAGENTS MARKET FOR PROBES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 61 ASIA PACIFIC: RESEARCH REAGENTS MARKET FOR PROBES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 62 LATIN AMERICA: RESEARCH REAGENTS MARKET FOR PROBES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 63 MIDDLE EAST & AFRICA: RESEARCH REAGENTS MARKET FOR FIXATIVES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 64 OTHER RESEARCH REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 65 NORTH AMERICA: OTHER RESEARCH REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 66 EUROPE: OTHER RESEARCH REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 67 ASIA PACIFIC: OTHER RESEARCH REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 68 LATIN AMERICA: OTHER RESEARCH REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 69 MIDDLE EAST & AFRICA: RESEARCH REAGENTS MARKET FOR OTHER RESEARCH REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 70 RESEARCH ANTIBODIES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 71 NORTH AMERICA: RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 72 EUROPE: RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 73 ASIA PACIFIC: RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 74 LATIN AMERICA: RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 75 MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 76 ANTIBODIES, BY TYPE AND APPLICATION
  • TABLE 77 RESEARCH ANTIBODIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 78 PRIMARY RESEARCH ANTIBODIES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 79 NORTH AMERICA: PRIMARY RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 80 EUROPE: PRIMARY RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 81 ASIA PACIFIC: PRIMARY RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 82 LATIN AMERICA: PRIMARY RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 83 MIDDLE EAST & AFRICA: PRIMARY RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 84 SECONDARY RESEARCH ANTIBODIES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 85 NORTH AMERICA: SECONDARY RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 86 EUROPE: SECONDARY RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 87 ASIA PACIFIC: SECONDARY RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 88 LATIN AMERICA: SECONDARY RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 89 MIDDLE EAST & AFRICA: SECONDARY RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 90 ANTIBODIES, BY FORM AND APPLICATION
  • TABLE 91 RESEARCH ANTIBODIES MARKET, BY FORM, 2021–2028 (USD MILLION)
  • TABLE 92 MONOCLONAL RESEARCH ANTIBODIES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 93 NORTH AMERICA: MONOCLONAL RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 94 EUROPE: MONOCLONAL RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 95 ASIA PACIFIC: MONOCLONAL RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 96 LATIN AMERICA: MONOCLONAL RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 97 MIDDLE EAST & AFRICA: MONOCLONAL RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 98 POLYCLONAL RESEARCH ANTIBODIES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 99 NORTH AMERICA: POLYCLONAL RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 100 EUROPE: POLYCLONAL RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 101 ASIA PACIFIC: POLYCLONAL RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 102 LATIN AMERICA: POLYCLONAL RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 103 MIDDLE EAST & AFRICA: POLYCLONAL RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 104 RECOMBINANT RESEARCH ANTIBODIES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 105 NORTH AMERICA: RECOMBINANT RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 106 EUROPE: RECOMBINANT RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 107 ASIA PACIFIC: RECOMBINANT RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 108 LATIN AMERICA: RECOMBINANT RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 109 MIDDLE EAST & AFRICA: RECOMBINANT RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 110 ANTIBODIES, BY SOURCE AND APPLICATION
  • TABLE 111 RESEARCH ANTIBODIES MARKET, BY SOURCE, 2021–2028 (USD MILLION)
  • TABLE 112 MICE ANTIBODIES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 113 NORTH AMERICA: MICE ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 114 EUROPE: MICE ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 115 ASIA PACIFIC: MICE ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 116 LATIN AMERICA: MICE ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 117 MIDDLE EAST & AFRICA: MICE ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 118 RABBIT ANTIBODIES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 119 NORTH AMERICA: RABBIT ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 120 EUROPE: RABBIT ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 121 ASIA PACIFIC: RABBIT ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 122 LATIN AMERICA: RABBIT ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 123 MIDDLE EAST & AFRICA: RABBIT ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 124 OTHER ANTIBODY SOURCES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 125 NORTH AMERICA: OTHER ANTIBODY SOURCES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 126 EUROPE: OTHER ANTIBODY SOURCES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 127 ASIA PACIFIC: OTHER ANTIBODY SOURCES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 128 LATIN AMERICA: OTHER ANTIBODY SOURCES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 129 MIDDLE EAST & AFRICA: OTHER ANTIBODY SOURCES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 130 ANTIBODIES, BY RESEARCH AREA AND APPLICATION
  • TABLE 131 RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2021–2028 (USD MILLION)
  • TABLE 132 RESEARCH ANTIBODIES MARKET FOR ONCOLOGY, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 133 NORTH AMERICA: RESEARCH ANTIBODIES MARKET FOR ONCOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 134 EUROPE: RESEARCH ANTIBODIES MARKET FOR ONCOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 135 ASIA PACIFIC: RESEARCH ANTIBODIES MARKET FOR ONCOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 136 LATIN AMERICA: RESEARCH ANTIBODIES MARKET FOR ONCOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 137 MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES MARKET FOR ONCOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 138 RESEARCH ANTIBODIES MARKET FOR INFECTIOUS DISEASES, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 139 NORTH AMERICA: RESEARCH ANTIBODIES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 140 EUROPE: RESEARCH ANTIBODIES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 141 ASIA PACIFIC: RESEARCH ANTIBODIES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 142 LATIN AMERICA: RESEARCH ANTIBODIES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 143 MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 144 RESEARCH ANTIBODIES MARKET FOR IMMUNOLOGY, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 145 NORTH AMERICA: RESEARCH ANTIBODIES MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 146 EUROPE: RESEARCH ANTIBODIES MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 147 ASIA PACIFIC: RESEARCH ANTIBODIES MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 148 LATIN AMERICA: RESEARCH ANTIBODIES MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 149 MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 150 RESEARCH ANTIBODIES MARKET FOR NEUROBIOLOGY, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 151 NORTH AMERICA: RESEARCH ANTIBODIES MARKET FOR NEUROBIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 152 EUROPE: RESEARCH ANTIBODIES MARKET FOR NEUROBIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 153 ASIA PACIFIC: RESEARCH ANTIBODIES MARKET FOR NEUROBIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 154 LATIN AMERICA: RESEARCH ANTIBODIES MARKET FOR NEUROBIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 155 MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES MARKET FOR NEUROBIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 156 RESEARCH ANTIBODIES MARKET FOR STEM CELLS, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 157 NORTH AMERICA: RESEARCH ANTIBODIES MARKET FOR STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 158 EUROPE: RESEARCH ANTIBODIES MARKET FOR STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 159 ASIA PACIFIC: RESEARCH ANTIBODIES MARKET FOR STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 160 LATIN AMERICA: RESEARCH ANTIBODIES MARKET FOR STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 161 MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES MARKET FOR STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 162 RESEARCH ANTIBODIES MARKET FOR OTHER RESEARCH AREAS, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 163 NORTH AMERICA: RESEARCH ANTIBODIES MARKET FOR OTHER RESEARCH AREAS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 164 EUROPE: RESEARCH ANTIBODIES MARKET FOR OTHER RESEARCH AREAS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 165 ASIA PACIFIC: RESEARCH ANTIBODIES MARKET FOR OTHER RESEARCH AREAS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 166 LATIN AMERICA: RESEARCH ANTIBODIES MARKET FOR OTHER RESEARCH AREAS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 167 MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES MARKET FOR OTHER RESEARCH AREAS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 168 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 169 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR ELISA, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 170 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR ELISA, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 171 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR ELISA, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 172 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR ELISA, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 173 LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR ELISA, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 174 MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR ELISA, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 175 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR FLOW CYTOMETRY, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 176 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 177 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 178 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 179 LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 180 MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 181 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR WESTERN BLOTTING, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 182 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR WESTERN BLOTTING, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 183 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR WESTERN BLOTTING, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 184 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR WESTERN BLOTTING, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 185 LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR WESTERN BLOTTING, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 186 MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR WESTERN BLOTTING, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 187 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR IMMUNOFLUORESCENCE, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 188 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 189 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 190 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 191 LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 192 MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 193 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 194 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 195 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 196 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 197 LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 198 MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 199 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR IMMUNOPRECIPITATION, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 200 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR IMMUNOPRECIPITATION, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 201 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR IMMUNOPRECIPITATION, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 202 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR IMMUNOPRECIPITATION, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 203 LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR IMMUNOPRECIPITATION, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 204 MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR IMMUNOPRECIPITATION, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 205 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 206 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 207 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 208 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 209 LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 210 MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 211 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 212 TECHNOLOGICAL APPLICATIONS OF ANTIBODIES IN PROTEOMICS
  • TABLE 213 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR PROTEOMICS, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 214 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR PROTEOMICS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 215 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR PROTEOMICS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 216 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR PROTEOMICS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 217 LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR PROTEOMICS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 218 MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR PROTEOMICS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 219 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR DRUG DEVELOPMENT, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 220 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR DRUG DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 221 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR DRUG DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 222 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR DRUG DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 223 LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR DRUG DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 224 MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR DRUG DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 225 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR GENOMICS, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 226 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR GENOMICS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 227 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR GENOMICS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 228 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR GENOMICS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 229 LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR GENOMICS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 230 MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR GENOMICS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 231 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 232 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR RESEARCH LABORATORIES, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 233 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 234 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 235 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 236 LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 237 MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 238 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 239 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 240 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 241 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 242 LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 243 MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 244 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 245 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 246 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 247 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 248 LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 249 MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES AND REAGENTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 250 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 251 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 252 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 253 NORTH AMERICA: RESEARCH REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 254 NORTH AMERICA: RESEARCH ANTIBODIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 255 NORTH AMERICA: RESEARCH ANTIBODIES MARKET, BY FORM, 2021–2028 (USD MILLION)
  • TABLE 256 NORTH AMERICA: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2021–2028 (USD MILLION)
  • TABLE 257 NORTH AMERICA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2021–2028 (USD MILLION)
  • TABLE 258 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 259 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 260 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 261 US NIH BUDGET FOR DISCIPLINES, FY 2019 TO FY 2022 (USD BILLION)
  • TABLE 262 US: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 263 US: RESEARCH REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 264 US: RESEARCH ANTIBODIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 265 US: RESEARCH ANTIBODIES MARKET, BY FORM, 2021–2028 (USD MILLION)
  • TABLE 266 US: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2021–2028 (USD MILLION)
  • TABLE 267 US: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2021–2028 (USD MILLION)
  • TABLE 268 US: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 269 US: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 270 US: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 271 CANADA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 272 CANADA: RESEARCH REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 273 CANADA: RESEARCH ANTIBODIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 274 CANADA: RESEARCH ANTIBODIES MARKET, BY FORM, 2021–2028 (USD MILLION)
  • TABLE 275 CANADA: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2021–2028 (USD MILLION)
  • TABLE 276 CANADA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2021–2028 (USD MILLION)
  • TABLE 277 CANADA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 278 CANADA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 279 CANADA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 280 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 281 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 282 EUROPE: RESEARCH REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 283 EUROPE: RESEARCH ANTIBODIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 284 EUROPE: RESEARCH ANTIBODIES MARKET, BY FORM, 2021–2028 (USD MILLION)
  • TABLE 285 EUROPE: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2021–2028 (USD MILLION)
  • TABLE 286 EUROPE: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2021–2028 (USD MILLION)
  • TABLE 287 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 288 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 289 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 290 GERMANY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 291 GERMANY: RESEARCH REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 292 GERMANY: RESEARCH ANTIBODIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 293 GERMANY: RESEARCH ANTIBODIES MARKET, BY FORM, 2021–2028 (USD MILLION)
  • TABLE 294 GERMANY: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2021–2028 (USD MILLION)
  • TABLE 295 GERMANY: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2021–2028 (USD MILLION)
  • TABLE 296 GERMANY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 297 GERMANY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 298 GERMANY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 299 UK: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 300 UK: RESEARCH REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 301 UK: RESEARCH ANTIBODIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 302 UK: RESEARCH ANTIBODIES MARKET, BY FORM, 2021–2028 (USD MILLION)
  • TABLE 303 UK: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2021–2028 (USD MILLION)
  • TABLE 304 UK: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2021–2028 (USD MILLION)
  • TABLE 305 UK: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 306 UK: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 307 UK: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 308 FRANCE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 309 FRANCE: RESEARCH REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 310 FRANCE: RESEARCH ANTIBODIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 311 FRANCE: RESEARCH ANTIBODIES MARKET, BY FORM, 2021–2028 (USD MILLION)
  • TABLE 312 FRANCE: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2021–2028 (USD MILLION)
  • TABLE 313 FRANCE: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2021–2028 (USD MILLION)
  • TABLE 314 FRANCE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 315 FRANCE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 316 FRANCE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 317 ITALY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 318 ITALY: RESEARCH REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 319 ITALY: RESEARCH ANTIBODIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 320 ITALY: RESEARCH ANTIBODIES MARKET, BY FORM, 2021–2028 (USD MILLION)
  • TABLE 321 ITALY: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2021–2028 (USD MILLION)
  • TABLE 322 ITALY: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2021–2028 (USD MILLION)
  • TABLE 323 ITALY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 324 ITALY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 325 ITALY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 326 SPAIN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 327 SPAIN: RESEARCH REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 328 SPAIN: RESEARCH ANTIBODIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 329 SPAIN: RESEARCH ANTIBODIES MARKET, BY FORM, 2021–2028 (USD MILLION)
  • TABLE 330 SPAIN: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2021–2028 (USD MILLION)
  • TABLE 331 SPAIN: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2021–2028 (USD MILLION)
  • TABLE 332 SPAIN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 333 SPAIN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 334 SPAIN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 335 REST OF EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 336 REST OF EUROPE: RESEARCH REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 337 REST OF EUROPE: RESEARCH ANTIBODIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 338 REST OF EUROPE: RESEARCH ANTIBODIES MARKET, BY FORM, 2021–2028 (USD MILLION)
  • TABLE 339 REST OF EUROPE: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2021–2028 (USD MILLION)
  • TABLE 340 REST OF EUROPE: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2021–2028 (USD MILLION)
  • TABLE 341 REST OF EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 342 REST OF EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 343 REST OF EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 344 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 345 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 346 ASIA PACIFIC: RESEARCH REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 347 ASIA PACIFIC: RESEARCH ANTIBODIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 348 ASIA PACIFIC: RESEARCH ANTIBODIES MARKET, BY FORM, 2021–2028 (USD MILLION)
  • TABLE 349 ASIA PACIFIC: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2021–2028 (USD MILLION)
  • TABLE 350 ASIA PACIFIC: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2021–2028 (USD MILLION)
  • TABLE 351 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 352 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 353 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 354 CHINA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 355 CHINA: RESEARCH REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 356 CHINA: RESEARCH ANTIBODIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 357 CHINA: RESEARCH ANTIBODIES MARKET, BY FORM, 2021–2028 (USD MILLION)
  • TABLE 358 CHINA: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2021–2028 (USD MILLION)
  • TABLE 359 CHINA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2021–2028 (USD MILLION)
  • TABLE 360 CHINA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 361 CHINA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 362 CHINA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 363 JAPAN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 364 JAPAN: RESEARCH REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 365 JAPAN: RESEARCH ANTIBODIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 366 JAPAN: RESEARCH ANTIBODIES MARKET, BY FORM, 2021–2028 (USD MILLION)
  • TABLE 367 JAPAN: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2021–2028 (USD MILLION)
  • TABLE 368 JAPAN: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2021–2028 (USD MILLION)
  • TABLE 369 JAPAN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 370 JAPAN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 371 JAPAN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 372 INDIA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 373 INDIA: RESEARCH REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 374 INDIA: RESEARCH ANTIBODIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 375 INDIA: RESEARCH ANTIBODIES MARKET, BY FORM, 2021–2028 (USD MILLION)
  • TABLE 376 INDIA: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2021–2028 (USD MILLION)
  • TABLE 377 INDIA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2021–2028 (USD MILLION)
  • TABLE 378 INDIA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 379 INDIA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 380 INDIA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 381 REST OF ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 382 REST OF ASIA PACIFIC: RESEARCH REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 383 REST OF ASIA PACIFIC: RESEARCH ANTIBODIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 384 REST OF ASIA PACIFIC: RESEARCH ANTIBODIES MARKET, BY FORM, 2021–2028 (USD MILLION)
  • TABLE 385 REST OF ASIA PACIFIC: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2021–2028 (USD MILLION)
  • TABLE 386 REST OF ASIA PACIFIC: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2021–2028 (USD MILLION)
  • TABLE 387 REST OF ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 388 REST OF ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 389 REST OF ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 390 LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 391 LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 392 LATIN AMERICA: RESEARCH REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 393 LATIN AMERICA: RESEARCH ANTIBODIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 394 LATIN AMERICA: RESEARCH ANTIBODIES MARKET, BY FORM, 2021–2028 (USD MILLION)
  • TABLE 395 LATIN AMERICA: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2021–2028 (USD MILLION)
  • TABLE 396 LATIN AMERICA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2021–2028 (USD MILLION)
  • TABLE 397 LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 398 LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 399 LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 400 BRAZIL: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 401 BRAZIL: RESEARCH REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 402 BRAZIL: RESEARCH ANTIBODIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 403 BRAZIL: RESEARCH ANTIBODIES MARKET, BY FORM, 2021–2028 (USD MILLION)
  • TABLE 404 BRAZIL: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2021–2028 (USD MILLION)
  • TABLE 405 BRAZIL: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2021–2028 (USD MILLION)
  • TABLE 406 BRAZIL: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 407 BRAZIL: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 408 BRAZIL: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 409 REST OF LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 410 REST OF LATIN AMERICA: RESEARCH REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 411 REST OF LATIN AMERICA: RESEARCH ANTIBODIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 412 REST OF LATIN AMERICA: RESEARCH ANTIBODIES MARKET, BY FORM, 2021–2028 (USD MILLION)
  • TABLE 413 REST OF LATIN AMERICA: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2021–2028 (USD MILLION)
  • TABLE 414 REST OF LATIN AMERICA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2021–2028 (USD MILLION)
  • TABLE 415 REST OF LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 416 REST OF LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 417 REST OF LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 418 MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 419 MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 420 MIDDLE EAST & AFRICA: RESEARCH REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 421 MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 422 MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES MARKET, BY FORM, 2021–2028 (USD MILLION)
  • TABLE 423 MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2021–2028 (USD MILLION)
  • TABLE 424 MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2021–2028 (USD MILLION)
  • TABLE 425 MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 426 MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 427 MIDDLE EAST & AFRICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 428 MIDDLE EAST: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 429 MIDDLE EAST: RESEARCH REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 430 MIDDLE EAST: RESEARCH ANTIBODIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 431 MIDDLE EAST: RESEARCH ANTIBODIES MARKET, BY FORM, 2021–2028 (USD MILLION)
  • TABLE 432 MIDDLE EAST: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2021–2028 (USD MILLION)
  • TABLE 433 MIDDLE EAST: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2021–2028 (USD MILLION)
  • TABLE 434 MIDDLE EAST: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 435 MIDDLE EAST: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 436 MIDDLE EAST: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 437 AFRICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 438 AFRICA: RESEARCH REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 439 AFRICA: RESEARCH ANTIBODIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 440 AFRICA: RESEARCH ANTIBODIES MARKET, BY FORM, 2021–2028 (USD MILLION)
  • TABLE 441 AFRICA: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2021–2028 (USD MILLION)
  • TABLE 442 AFRICA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2021–2028 (USD MILLION)
  • TABLE 443 AFRICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 444 AFRICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
  • TABLE 445 AFRICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 446 RESEARCH ANTIBODIES AND REAGENTS MARKET: INTENSITY OF COMPETITIVE RIVALRY
  • TABLE 447 COMPANY FOOTPRINT ANALYSIS
  • TABLE 448 PRODUCT FOOTPRINT ANALYSIS
  • TABLE 449 REGIONAL FOOTPRINT ANALYSIS
  • TABLE 450 RESEARCH ANTIBODIES MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 451 RESEARCH ANTIBODIES AND REAGENTS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  • TABLE 452 RESEARCH ANTIBODIES AND REAGENTS MARKET: PRODUCT LAUNCHES (2020−2023)
  • TABLE 453 RESEARCH ANTIBODIES AND REAGENTS MARKET: DEALS (2020−2023)
  • TABLE 454 RESEARCH ANTIBODIES AND REAGENTS MARKET: OTHER DEVELOPMENTS (2020−2023)
  • TABLE 455 ABCAM PLC: BUSINESS OVERVIEW
  • TABLE 456 CELL SIGNALING TECHNOLOGY, INC.: BUSINESS OVERVIEW
  • TABLE 457 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
  • TABLE 458 MERCK KGAA: BUSINESS OVERVIEW
  • TABLE 459 BD: BUSINESS OVERVIEW
  • TABLE 460 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
  • TABLE 461 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
  • TABLE 462 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
  • TABLE 463 DANAHER: BUSINESS OVERVIEW
  • TABLE 464 LONZA GROUP: BUSINESS OVERVIEW
  • TABLE 465 GENSCRIPT: BUSINESS OVERVIEW
  • TABLE 466 REVVITY: BUSINESS OVERVIEW
  • TABLE 467 ILLUMINA, INC.: BUSINESS OVERVIEW
  • TABLE 468 IMMUNOPRECISE ANTIBODIES LTD.: COMPANY OVERVIEW
  • TABLE 469 FUJIREBIO: COMPANY OVERVIEW
  • TABLE 470 ANALYTIK JENA GMBH+CO. KG: COMPANY OVERVIEW
  • TABLE 471 OMEGA BIO-TEK, INC.: COMPANY OVERVIEW
  • TABLE 472 DOVETAIL GENOMICS: COMPANY OVERVIEW
  • TABLE 473 ATLAS ANTIBODIES AB: COMPANY OVERVIEW
  • TABLE 474 ROCKLAND IMMUNOCHEMICALS, INC.: BUSINESS OVERVIEW
  • TABLE 475 SANTA CRUZ BIOTECHNOLOGY, INC.: COMPANY OVERVIEW
  • TABLE 476 JACKSON IMMUNORESEARCH INC.: COMPANY OVERVIEW
  • TABLE 477 PROTEINTECH GROUP, INC.: COMPANY OVERVIEW
  • TABLE 478 ICL, INC.: COMPANY OVERVIEW
  • TABLE 479 SOUTHERNBIOTECH: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 RESEARCH ANTIBODIES AND REAGENTS MARKET
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 BREAKDOWN OF PRIMARIES
  • FIGURE 4 MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS) FOR 2022
  • FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS METHODOLOGY
  • FIGURE 6 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022
  • FIGURE 7 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS (2022)
  • FIGURE 8 MARKET VALIDATION FROM PRIMARY SOURCES
  • FIGURE 9 TOP-DOWN APPROACH
  • FIGURE 10 CAGR PROJECTIONS
  • FIGURE 11 RESEARCH ANTIBODIES AND REAGENTS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES
  • FIGURE 12 DATA TRIANGULATION METHODOLOGY
  • FIGURE 13 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
  • FIGURE 14 RESEARCH ANTIBODIES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
  • FIGURE 15 RESEARCH REAGENTS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
  • FIGURE 16 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
  • FIGURE 17 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
  • FIGURE 18 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
  • FIGURE 19 GEOGRAPHIC SNAPSHOT OF RESEARCH ANTIBODIES AND REAGENTS MARKET
  • FIGURE 20 RISING FUNDING INVESTMENTS IN LIFE SCIENCES RESEARCH TO DRIVE MARKET GROWTH DURING FORECAST PERIOD
  • FIGURE 21 PROTEOMICS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
  • FIGURE 22 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 23 ASIA PACIFIC SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 24 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 25 RESEARCH ANTIBODIES AND REAGENTS MARKET: DRIVERS, OPPORTUNITIES, RESTRAINTS, AND CHALLENGES
  • FIGURE 26 RESEARCH ANTIBODIES AND REAGENTS MARKETS: SUPPLY SIDE ANALYSIS
  • FIGURE 27 REVENUE SHIFT AND REVENUE GROWTH
  • FIGURE 28 RESEARCH ANTIBODIES AND REAGENT MARKET: PATENT ANALYSIS
  • FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR RESEARCH ANTIBODY & REAGENT PRODUCTS
  • FIGURE 30 BUYING CRITERIA FOR PRODUCTS, BY END USER
  • FIGURE 31 APPLICATION OF ANTIBODIES IN DRUG DEVELOPMENT PROCESS
  • FIGURE 32 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET SNAPSHOT
  • FIGURE 33 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET SNAPSHOT
  • FIGURE 34 KEY DEVELOPMENTS IN RESEARCH ANTIBODIES AND REAGENTS MARKET
  • FIGURE 35 MARKET SHARE ANALYSIS FOR OVERALL MARKET, BY KEY PLAYER (2022)
  • FIGURE 36 RESEARCH ANTIBODIES MARKET: MARKET SHARE ANALYSIS, BY KEY PLAYER (2022)
  • FIGURE 37 REVENUE SHARE ANALYSIS OF TOP PLAYERS (2020–2022)
  • FIGURE 38 RESEARCH ANTIBODIES AND REAGENTS MARKET: COMPANY EVALUATION MATRIX (2022)
  • FIGURE 39 RESEARCH ANTIBODIES AND REAGENTS MARKET: COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES (2022)
  • FIGURE 40 ABCAM PLC: COMPANY SNAPSHOT (2022)
  • FIGURE 41 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
  • FIGURE 42 MERCK KGAA: COMPANY SNAPSHOT (2022)
  • FIGURE 43 BD: COMPANY SNAPSHOT (2022)
  • FIGURE 44 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
  • FIGURE 45 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
  • FIGURE 46 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2022)
  • FIGURE 47 DANAHER: COMPANY SNAPSHOT (2022)
  • FIGURE 48 LONZA GROUP: COMPANY SNAPSHOT (2022)
  • FIGURE 49 GENSCRIPT: COMPANY SNAPSHOT (2022)
  • FIGURE 50 PERKINELMER INC.: COMPANY SNAPSHOT (2022)
  • FIGURE 51 ILLUMINA, INC.: COMPANY SNAPSHOT (2022)

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

This research study involved the use of widespread secondary sources; directories; databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva; white papers; annual reports; and companies’ house documents. Secondary research was used to identify and collect information for this extensive, technical, market-oriented, and commercial study of the global research antibodies and reagents market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, key developments related to market, and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side included industry experts, such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the global research antibodies and reagents market. The primary sources from the demand side included industry experts, such as life science researchers.

A breakdown of the primary respondents is provided below:

Research Antibodies and Reagents Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by product, technology, application, end user, and region).

Bottom-up Approach

  • The key players in the industry and market have been identified through extensive secondary research.
  • The revenues generated from the research antibodies and reagents business of leading players have been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Research Antibodies and Reagents Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Top-down Approach

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

Research Antibodies and Reagents Market Size, and Share

Data Triangulation

To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Antibodies are proteins that bind to specific antigens, and reagents are chemicals or other substances used in chemical reactions. Antibodies and reagents are important components in life science research for the investigation of biological processes or causes of diseases through careful experimentation, observation, laboratory work, analysis, and testing.

Stakeholders

  • Pharmaceutical and Biotechnology Companies
  • Research Laboratories
  • Life Sciences Companies
  • Academic Research Institutes
  • Government Institutes
  • Private Research Firms
  • Contract Research Organizations (CROs)
  • Venture Capitalists and Investors

Objectives of the Study

  • To define, describe, segment, and forecast the global research antibodies and reagents market based on the product, technology, application, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and industry-specific challenges)
  • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze the market opportunities for stakeholders and provide details of the competitive landscape for market players
  • To forecast the size of the global research antibodies and reagents market in five main regions (along with countries)—North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East and Africa (MEA)
  • To profile key players in the global research antibodies and reagents market and comprehensively analyze their core competencies2 and market shares
  • To track and analyze competitive developments, such as product/technology development, partnerships, mergers, acquisitions, and expansions, and the R&D activities of the leading players in the research antibodies and reagents market
  • To benchmark players within the research antibodies and reagents market using the "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Portfolio Assessment

  • Product Matrix, which gives a detailed comparison of the product portfolios of the top three companies.

Company Information

  • Detailed analysis and profiling of additional market players (up to three).

Geographical Analysis

  • A further breakdown of the Rest of Asia Pacific research antibodies and reagents market into countries
  • A further breakdown of the Rest of European research antibodies and reagents market into countries
  • A further breakdown of the Rest of Latin American research antibodies and reagents market into countries

Previous Versions of this Report

Research Antibodies & Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western blot, Flow Cytometry, ELISA), Application (Proteomics, Genomics), End User (Pharma, Biotech, CROs) - Global forecast to 2027

Report Code BT 5482
Published in Jul, 2022, By MarketsandMarkets™

Research Antibodies & Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western blotting, Flow Cytometry), Application (Proteomics, Drug Development), End User - COVID-19 Impact - Global Forecast to 2025

Report Code BT 5482
Published in Oct, 2020, By MarketsandMarkets™

Research Antibodies & Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western blotting, Flow Cytometry), Application (Proteomics, Drug Development), End User - COVID-19 Impact - Global Forecast to 2025

Report Code BT 5482
Published in Aug, 2017, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Research Antibodies & Reagents Market

DMCA.com Protection Status